玮俊生物科技(00660)发布中期业绩,股东应占亏损1366.1万港元,同比扩大102.87%

智通财经网
28 Feb

智通财经APP讯,玮俊生物科技(00660)发布截至2024年12月31日止6个月中期业绩,收入1.61亿港元,同比减少15.38%;股东应占亏损1366.1万港元,同比扩大102.87%;每股亏损7.97港仙。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10